Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retosiban versus placebo in spontaneous preterm labor (Phase III)
2014-003326-41Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Preterm labor (PTL) comparing Retosiban IV with Placebo IV (2 arms). Primary endpoint: Time to delivery or treatment failure. Started Nov 2015; status: completed.
02
Drugs
retosiban
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on 2014-003326-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003326-41.